Global Precision Oncology Market Growth (Status and Outlook) 2026-2032
The global Precision Oncology market size is predicted to grow from US$ 121870 million in 2025 to US$ 237390 million in 2032; it is expected to grow at a CAGR of 10.2% from 2026 to 2032.
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
LPI (LP Information)' newest research report, the “Precision Oncology Industry Forecast” looks at past sales and reviews total world Precision Oncology sales in 2025, providing a comprehensive analysis by region and market sector of projected Precision Oncology sales for 2026 through 2032. With Precision Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Precision Oncology industry.
This Insight Report provides a comprehensive analysis of the global Precision Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Precision Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Precision Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Precision Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Precision Oncology.
This report presents a comprehensive overview, market shares, and growth opportunities of Precision Oncology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
LPI (LP Information)' newest research report, the “Precision Oncology Industry Forecast” looks at past sales and reviews total world Precision Oncology sales in 2025, providing a comprehensive analysis by region and market sector of projected Precision Oncology sales for 2026 through 2032. With Precision Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Precision Oncology industry.
This Insight Report provides a comprehensive analysis of the global Precision Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Precision Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Precision Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Precision Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Precision Oncology.
This report presents a comprehensive overview, market shares, and growth opportunities of Precision Oncology market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Diagnostics
- Therapeutics
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Healthcare Data Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Acrivon Therapeutics
- Bio-Serv
- Exact Sciences Corporation
- Illumina, Inc.
- Invitae Corporation
- Laboratory Corporation of America
- QIAGEN
- Rain Oncology
- Relay Therapeutics
- Strata Oncology, Inc.
- Thermo Fisher Scientific Inc.
- Variantyx, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Precision Oncology Market Size (2021-2032)
2.1.2 Precision Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Precision Oncology by Country/Region (2021, 2025 & 2032)
2.2 Precision Oncology Segment by Type
2.2.1 Diagnostics
2.2.2 Therapeutics
2.2.3 Precision Oncology Market Size by Type
2.2.3.1 Precision Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Precision Oncology Market Size Market Share by Type (2021-2026)
2.3 Precision Oncology Segment by Application
2.3.1 Pharmaceutical & Biotechnology Companies
2.3.2 Hospitals & Diagnostic Laboratories
2.3.3 Healthcare Data Companies
2.3.4 Precision Oncology Market Size by Application
2.3.4.1 Precision Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Precision Oncology Market Size Market Share by Application (2021-2026)
3 PRECISION ONCOLOGY MARKET SIZE BY PLAYER
3.1 Precision Oncology Market Size Market Share by Player
3.1.1 Global Precision Oncology Revenue by Player (2021-2026)
3.1.2 Global Precision Oncology Revenue Market Share by Player (2021-2026)
3.2 Global Precision Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRECISION ONCOLOGY BY REGION
4.1 Precision Oncology Market Size by Region (2021-2026)
4.2 Global Precision Oncology Annual Revenue by Country/Region (2021-2026)
4.3 Americas Precision Oncology Market Size Growth (2021-2026)
4.4 APAC Precision Oncology Market Size Growth (2021-2026)
4.5 Europe Precision Oncology Market Size Growth (2021-2026)
4.6 Middle East & Africa Precision Oncology Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Precision Oncology Market Size by Country (2021-2026)
5.2 Americas Precision Oncology Market Size by Type (2021-2026)
5.3 Americas Precision Oncology Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Precision Oncology Market Size by Region (2021-2026)
6.2 APAC Precision Oncology Market Size by Type (2021-2026)
6.3 APAC Precision Oncology Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Precision Oncology Market Size by Country (2021-2026)
7.2 Europe Precision Oncology Market Size by Type (2021-2026)
7.3 Europe Precision Oncology Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Precision Oncology by Region (2021-2026)
8.2 Middle East & Africa Precision Oncology Market Size by Type (2021-2026)
8.3 Middle East & Africa Precision Oncology Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRECISION ONCOLOGY MARKET FORECAST
10.1 Global Precision Oncology Forecast by Region (2027-2032)
10.1.1 Global Precision Oncology Forecast by Region (2027-2032)
10.1.2 Americas Precision Oncology Forecast
10.1.3 APAC Precision Oncology Forecast
10.1.4 Europe Precision Oncology Forecast
10.1.5 Middle East & Africa Precision Oncology Forecast
10.2 Americas Precision Oncology Forecast by Country (2027-2032)
10.2.1 United States Market Precision Oncology Forecast
10.2.2 Canada Market Precision Oncology Forecast
10.2.3 Mexico Market Precision Oncology Forecast
10.2.4 Brazil Market Precision Oncology Forecast
10.3 APAC Precision Oncology Forecast by Region (2027-2032)
10.3.1 China Precision Oncology Market Forecast
10.3.2 Japan Market Precision Oncology Forecast
10.3.3 Korea Market Precision Oncology Forecast
10.3.4 Southeast Asia Market Precision Oncology Forecast
10.3.5 India Market Precision Oncology Forecast
10.3.6 Australia Market Precision Oncology Forecast
10.4 Europe Precision Oncology Forecast by Country (2027-2032)
10.4.1 Germany Market Precision Oncology Forecast
10.4.2 France Market Precision Oncology Forecast
10.4.3 UK Market Precision Oncology Forecast
10.4.4 Italy Market Precision Oncology Forecast
10.4.5 Russia Market Precision Oncology Forecast
10.5 Middle East & Africa Precision Oncology Forecast by Region (2027-2032)
10.5.1 Egypt Market Precision Oncology Forecast
10.5.2 South Africa Market Precision Oncology Forecast
10.5.3 Israel Market Precision Oncology Forecast
10.5.4 Turkey Market Precision Oncology Forecast
10.6 Global Precision Oncology Forecast by Type (2027-2032)
10.7 Global Precision Oncology Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Precision Oncology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Acrivon Therapeutics
11.1.1 Acrivon Therapeutics Company Information
11.1.2 Acrivon Therapeutics Precision Oncology Product Offered
11.1.3 Acrivon Therapeutics Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Acrivon Therapeutics Main Business Overview
11.1.5 Acrivon Therapeutics Latest Developments
11.2 Bio-Serv
11.2.1 Bio-Serv Company Information
11.2.2 Bio-Serv Precision Oncology Product Offered
11.2.3 Bio-Serv Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Serv Main Business Overview
11.2.5 Bio-Serv Latest Developments
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Information
11.3.2 Exact Sciences Corporation Precision Oncology Product Offered
11.3.3 Exact Sciences Corporation Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Exact Sciences Corporation Main Business Overview
11.3.5 Exact Sciences Corporation Latest Developments
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Information
11.4.2 Illumina, Inc. Precision Oncology Product Offered
11.4.3 Illumina, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Illumina, Inc. Main Business Overview
11.4.5 Illumina, Inc. Latest Developments
11.5 Invitae Corporation
11.5.1 Invitae Corporation Company Information
11.5.2 Invitae Corporation Precision Oncology Product Offered
11.5.3 Invitae Corporation Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Invitae Corporation Main Business Overview
11.5.5 Invitae Corporation Latest Developments
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Information
11.6.2 Laboratory Corporation of America Precision Oncology Product Offered
11.6.3 Laboratory Corporation of America Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Laboratory Corporation of America Main Business Overview
11.6.5 Laboratory Corporation of America Latest Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Information
11.7.2 QIAGEN Precision Oncology Product Offered
11.7.3 QIAGEN Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 QIAGEN Main Business Overview
11.7.5 QIAGEN Latest Developments
11.8 Rain Oncology
11.8.1 Rain Oncology Company Information
11.8.2 Rain Oncology Precision Oncology Product Offered
11.8.3 Rain Oncology Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Rain Oncology Main Business Overview
11.8.5 Rain Oncology Latest Developments
11.9 Relay Therapeutics
11.9.1 Relay Therapeutics Company Information
11.9.2 Relay Therapeutics Precision Oncology Product Offered
11.9.3 Relay Therapeutics Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Relay Therapeutics Main Business Overview
11.9.5 Relay Therapeutics Latest Developments
11.10 Strata Oncology, Inc.
11.10.1 Strata Oncology, Inc. Company Information
11.10.2 Strata Oncology, Inc. Precision Oncology Product Offered
11.10.3 Strata Oncology, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Strata Oncology, Inc. Main Business Overview
11.10.5 Strata Oncology, Inc. Latest Developments
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Information
11.11.2 Thermo Fisher Scientific Inc. Precision Oncology Product Offered
11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Thermo Fisher Scientific Inc. Main Business Overview
11.11.5 Thermo Fisher Scientific Inc. Latest Developments
11.12 Variantyx, Inc.
11.12.1 Variantyx, Inc. Company Information
11.12.2 Variantyx, Inc. Precision Oncology Product Offered
11.12.3 Variantyx, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Variantyx, Inc. Main Business Overview
11.12.5 Variantyx, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Precision Oncology Market Size (2021-2032)
2.1.2 Precision Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Precision Oncology by Country/Region (2021, 2025 & 2032)
2.2 Precision Oncology Segment by Type
2.2.1 Diagnostics
2.2.2 Therapeutics
2.2.3 Precision Oncology Market Size by Type
2.2.3.1 Precision Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Precision Oncology Market Size Market Share by Type (2021-2026)
2.3 Precision Oncology Segment by Application
2.3.1 Pharmaceutical & Biotechnology Companies
2.3.2 Hospitals & Diagnostic Laboratories
2.3.3 Healthcare Data Companies
2.3.4 Precision Oncology Market Size by Application
2.3.4.1 Precision Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Precision Oncology Market Size Market Share by Application (2021-2026)
3 PRECISION ONCOLOGY MARKET SIZE BY PLAYER
3.1 Precision Oncology Market Size Market Share by Player
3.1.1 Global Precision Oncology Revenue by Player (2021-2026)
3.1.2 Global Precision Oncology Revenue Market Share by Player (2021-2026)
3.2 Global Precision Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRECISION ONCOLOGY BY REGION
4.1 Precision Oncology Market Size by Region (2021-2026)
4.2 Global Precision Oncology Annual Revenue by Country/Region (2021-2026)
4.3 Americas Precision Oncology Market Size Growth (2021-2026)
4.4 APAC Precision Oncology Market Size Growth (2021-2026)
4.5 Europe Precision Oncology Market Size Growth (2021-2026)
4.6 Middle East & Africa Precision Oncology Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Precision Oncology Market Size by Country (2021-2026)
5.2 Americas Precision Oncology Market Size by Type (2021-2026)
5.3 Americas Precision Oncology Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Precision Oncology Market Size by Region (2021-2026)
6.2 APAC Precision Oncology Market Size by Type (2021-2026)
6.3 APAC Precision Oncology Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Precision Oncology Market Size by Country (2021-2026)
7.2 Europe Precision Oncology Market Size by Type (2021-2026)
7.3 Europe Precision Oncology Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Precision Oncology by Region (2021-2026)
8.2 Middle East & Africa Precision Oncology Market Size by Type (2021-2026)
8.3 Middle East & Africa Precision Oncology Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRECISION ONCOLOGY MARKET FORECAST
10.1 Global Precision Oncology Forecast by Region (2027-2032)
10.1.1 Global Precision Oncology Forecast by Region (2027-2032)
10.1.2 Americas Precision Oncology Forecast
10.1.3 APAC Precision Oncology Forecast
10.1.4 Europe Precision Oncology Forecast
10.1.5 Middle East & Africa Precision Oncology Forecast
10.2 Americas Precision Oncology Forecast by Country (2027-2032)
10.2.1 United States Market Precision Oncology Forecast
10.2.2 Canada Market Precision Oncology Forecast
10.2.3 Mexico Market Precision Oncology Forecast
10.2.4 Brazil Market Precision Oncology Forecast
10.3 APAC Precision Oncology Forecast by Region (2027-2032)
10.3.1 China Precision Oncology Market Forecast
10.3.2 Japan Market Precision Oncology Forecast
10.3.3 Korea Market Precision Oncology Forecast
10.3.4 Southeast Asia Market Precision Oncology Forecast
10.3.5 India Market Precision Oncology Forecast
10.3.6 Australia Market Precision Oncology Forecast
10.4 Europe Precision Oncology Forecast by Country (2027-2032)
10.4.1 Germany Market Precision Oncology Forecast
10.4.2 France Market Precision Oncology Forecast
10.4.3 UK Market Precision Oncology Forecast
10.4.4 Italy Market Precision Oncology Forecast
10.4.5 Russia Market Precision Oncology Forecast
10.5 Middle East & Africa Precision Oncology Forecast by Region (2027-2032)
10.5.1 Egypt Market Precision Oncology Forecast
10.5.2 South Africa Market Precision Oncology Forecast
10.5.3 Israel Market Precision Oncology Forecast
10.5.4 Turkey Market Precision Oncology Forecast
10.6 Global Precision Oncology Forecast by Type (2027-2032)
10.7 Global Precision Oncology Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Precision Oncology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Acrivon Therapeutics
11.1.1 Acrivon Therapeutics Company Information
11.1.2 Acrivon Therapeutics Precision Oncology Product Offered
11.1.3 Acrivon Therapeutics Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Acrivon Therapeutics Main Business Overview
11.1.5 Acrivon Therapeutics Latest Developments
11.2 Bio-Serv
11.2.1 Bio-Serv Company Information
11.2.2 Bio-Serv Precision Oncology Product Offered
11.2.3 Bio-Serv Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Serv Main Business Overview
11.2.5 Bio-Serv Latest Developments
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Information
11.3.2 Exact Sciences Corporation Precision Oncology Product Offered
11.3.3 Exact Sciences Corporation Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Exact Sciences Corporation Main Business Overview
11.3.5 Exact Sciences Corporation Latest Developments
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Information
11.4.2 Illumina, Inc. Precision Oncology Product Offered
11.4.3 Illumina, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Illumina, Inc. Main Business Overview
11.4.5 Illumina, Inc. Latest Developments
11.5 Invitae Corporation
11.5.1 Invitae Corporation Company Information
11.5.2 Invitae Corporation Precision Oncology Product Offered
11.5.3 Invitae Corporation Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Invitae Corporation Main Business Overview
11.5.5 Invitae Corporation Latest Developments
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Information
11.6.2 Laboratory Corporation of America Precision Oncology Product Offered
11.6.3 Laboratory Corporation of America Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Laboratory Corporation of America Main Business Overview
11.6.5 Laboratory Corporation of America Latest Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Information
11.7.2 QIAGEN Precision Oncology Product Offered
11.7.3 QIAGEN Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 QIAGEN Main Business Overview
11.7.5 QIAGEN Latest Developments
11.8 Rain Oncology
11.8.1 Rain Oncology Company Information
11.8.2 Rain Oncology Precision Oncology Product Offered
11.8.3 Rain Oncology Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Rain Oncology Main Business Overview
11.8.5 Rain Oncology Latest Developments
11.9 Relay Therapeutics
11.9.1 Relay Therapeutics Company Information
11.9.2 Relay Therapeutics Precision Oncology Product Offered
11.9.3 Relay Therapeutics Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Relay Therapeutics Main Business Overview
11.9.5 Relay Therapeutics Latest Developments
11.10 Strata Oncology, Inc.
11.10.1 Strata Oncology, Inc. Company Information
11.10.2 Strata Oncology, Inc. Precision Oncology Product Offered
11.10.3 Strata Oncology, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Strata Oncology, Inc. Main Business Overview
11.10.5 Strata Oncology, Inc. Latest Developments
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Information
11.11.2 Thermo Fisher Scientific Inc. Precision Oncology Product Offered
11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Thermo Fisher Scientific Inc. Main Business Overview
11.11.5 Thermo Fisher Scientific Inc. Latest Developments
11.12 Variantyx, Inc.
11.12.1 Variantyx, Inc. Company Information
11.12.2 Variantyx, Inc. Precision Oncology Product Offered
11.12.3 Variantyx, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Variantyx, Inc. Main Business Overview
11.12.5 Variantyx, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Precision Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Precision Oncology Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Diagnostics
Table 4. Major Players of Therapeutics
Table 5. Precision Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Precision Oncology Market Size Market Share by Type (2021-2026)
Table 8. Precision Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Precision Oncology Market Size Market Share by Application (2021-2026)
Table 11. Global Precision Oncology Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Precision Oncology Revenue Market Share by Player (2021-2026)
Table 13. Precision Oncology Key Players Head office and Products Offered
Table 14. Precision Oncology Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Precision Oncology Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Precision Oncology Market Size Market Share by Region (2021-2026)
Table 19. Global Precision Oncology Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Precision Oncology Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Precision Oncology Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Precision Oncology Market Size Market Share by Country (2021-2026)
Table 23. Americas Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Precision Oncology Market Size Market Share by Type (2021-2026)
Table 25. Americas Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Precision Oncology Market Size Market Share by Application (2021-2026)
Table 27. APAC Precision Oncology Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Precision Oncology Market Size Market Share by Region (2021-2026)
Table 29. APAC Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Precision Oncology Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Precision Oncology Market Size Market Share by Country (2021-2026)
Table 33. Europe Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Precision Oncology Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Precision Oncology
Table 39. Key Market Challenges & Risks of Precision Oncology
Table 40. Key Industry Trends of Precision Oncology
Table 41. Global Precision Oncology Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Precision Oncology Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Precision Oncology Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Precision Oncology Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Acrivon Therapeutics Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 46. Acrivon Therapeutics Precision Oncology Product Offered
Table 47. Acrivon Therapeutics Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Acrivon Therapeutics Main Business
Table 49. Acrivon Therapeutics Latest Developments
Table 50. Bio-Serv Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 51. Bio-Serv Precision Oncology Product Offered
Table 52. Bio-Serv Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bio-Serv Main Business
Table 54. Bio-Serv Latest Developments
Table 55. Exact Sciences Corporation Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 56. Exact Sciences Corporation Precision Oncology Product Offered
Table 57. Exact Sciences Corporation Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Exact Sciences Corporation Main Business
Table 59. Exact Sciences Corporation Latest Developments
Table 60. Illumina, Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 61. Illumina, Inc. Precision Oncology Product Offered
Table 62. Illumina, Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Illumina, Inc. Main Business
Table 64. Illumina, Inc. Latest Developments
Table 65. Invitae Corporation Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 66. Invitae Corporation Precision Oncology Product Offered
Table 67. Invitae Corporation Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Invitae Corporation Main Business
Table 69. Invitae Corporation Latest Developments
Table 70. Laboratory Corporation of America Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 71. Laboratory Corporation of America Precision Oncology Product Offered
Table 72. Laboratory Corporation of America Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Laboratory Corporation of America Main Business
Table 74. Laboratory Corporation of America Latest Developments
Table 75. QIAGEN Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 76. QIAGEN Precision Oncology Product Offered
Table 77. QIAGEN Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. QIAGEN Main Business
Table 79. QIAGEN Latest Developments
Table 80. Rain Oncology Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 81. Rain Oncology Precision Oncology Product Offered
Table 82. Rain Oncology Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Rain Oncology Main Business
Table 84. Rain Oncology Latest Developments
Table 85. Relay Therapeutics Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 86. Relay Therapeutics Precision Oncology Product Offered
Table 87. Relay Therapeutics Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Relay Therapeutics Main Business
Table 89. Relay Therapeutics Latest Developments
Table 90. Strata Oncology, Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 91. Strata Oncology, Inc. Precision Oncology Product Offered
Table 92. Strata Oncology, Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Strata Oncology, Inc. Main Business
Table 94. Strata Oncology, Inc. Latest Developments
Table 95. Thermo Fisher Scientific Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 96. Thermo Fisher Scientific Inc. Precision Oncology Product Offered
Table 97. Thermo Fisher Scientific Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Thermo Fisher Scientific Inc. Main Business
Table 99. Thermo Fisher Scientific Inc. Latest Developments
Table 100. Variantyx, Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 101. Variantyx, Inc. Precision Oncology Product Offered
Table 102. Variantyx, Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Variantyx, Inc. Main Business
Table 104. Variantyx, Inc. Latest Developments
Table 1. Precision Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Precision Oncology Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Diagnostics
Table 4. Major Players of Therapeutics
Table 5. Precision Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Precision Oncology Market Size Market Share by Type (2021-2026)
Table 8. Precision Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Precision Oncology Market Size Market Share by Application (2021-2026)
Table 11. Global Precision Oncology Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Precision Oncology Revenue Market Share by Player (2021-2026)
Table 13. Precision Oncology Key Players Head office and Products Offered
Table 14. Precision Oncology Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Precision Oncology Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Precision Oncology Market Size Market Share by Region (2021-2026)
Table 19. Global Precision Oncology Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Precision Oncology Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Precision Oncology Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Precision Oncology Market Size Market Share by Country (2021-2026)
Table 23. Americas Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Precision Oncology Market Size Market Share by Type (2021-2026)
Table 25. Americas Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Precision Oncology Market Size Market Share by Application (2021-2026)
Table 27. APAC Precision Oncology Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Precision Oncology Market Size Market Share by Region (2021-2026)
Table 29. APAC Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Precision Oncology Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Precision Oncology Market Size Market Share by Country (2021-2026)
Table 33. Europe Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Precision Oncology Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Precision Oncology Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Precision Oncology Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Precision Oncology
Table 39. Key Market Challenges & Risks of Precision Oncology
Table 40. Key Industry Trends of Precision Oncology
Table 41. Global Precision Oncology Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Precision Oncology Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Precision Oncology Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Precision Oncology Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Acrivon Therapeutics Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 46. Acrivon Therapeutics Precision Oncology Product Offered
Table 47. Acrivon Therapeutics Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Acrivon Therapeutics Main Business
Table 49. Acrivon Therapeutics Latest Developments
Table 50. Bio-Serv Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 51. Bio-Serv Precision Oncology Product Offered
Table 52. Bio-Serv Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bio-Serv Main Business
Table 54. Bio-Serv Latest Developments
Table 55. Exact Sciences Corporation Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 56. Exact Sciences Corporation Precision Oncology Product Offered
Table 57. Exact Sciences Corporation Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Exact Sciences Corporation Main Business
Table 59. Exact Sciences Corporation Latest Developments
Table 60. Illumina, Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 61. Illumina, Inc. Precision Oncology Product Offered
Table 62. Illumina, Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Illumina, Inc. Main Business
Table 64. Illumina, Inc. Latest Developments
Table 65. Invitae Corporation Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 66. Invitae Corporation Precision Oncology Product Offered
Table 67. Invitae Corporation Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Invitae Corporation Main Business
Table 69. Invitae Corporation Latest Developments
Table 70. Laboratory Corporation of America Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 71. Laboratory Corporation of America Precision Oncology Product Offered
Table 72. Laboratory Corporation of America Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Laboratory Corporation of America Main Business
Table 74. Laboratory Corporation of America Latest Developments
Table 75. QIAGEN Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 76. QIAGEN Precision Oncology Product Offered
Table 77. QIAGEN Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. QIAGEN Main Business
Table 79. QIAGEN Latest Developments
Table 80. Rain Oncology Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 81. Rain Oncology Precision Oncology Product Offered
Table 82. Rain Oncology Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Rain Oncology Main Business
Table 84. Rain Oncology Latest Developments
Table 85. Relay Therapeutics Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 86. Relay Therapeutics Precision Oncology Product Offered
Table 87. Relay Therapeutics Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Relay Therapeutics Main Business
Table 89. Relay Therapeutics Latest Developments
Table 90. Strata Oncology, Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 91. Strata Oncology, Inc. Precision Oncology Product Offered
Table 92. Strata Oncology, Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Strata Oncology, Inc. Main Business
Table 94. Strata Oncology, Inc. Latest Developments
Table 95. Thermo Fisher Scientific Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 96. Thermo Fisher Scientific Inc. Precision Oncology Product Offered
Table 97. Thermo Fisher Scientific Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Thermo Fisher Scientific Inc. Main Business
Table 99. Thermo Fisher Scientific Inc. Latest Developments
Table 100. Variantyx, Inc. Details, Company Type, Precision Oncology Area Served and Its Competitors
Table 101. Variantyx, Inc. Precision Oncology Product Offered
Table 102. Variantyx, Inc. Precision Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Variantyx, Inc. Main Business
Table 104. Variantyx, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Precision Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Precision Oncology Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Precision Oncology Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Precision Oncology Sales Market Share by Country/Region (2025)
Figure 8. Precision Oncology Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Precision Oncology Market Size Market Share by Type in 2025
Figure 10. Precision Oncology in Pharmaceutical & Biotechnology Companies
Figure 11. Global Precision Oncology Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 12. Precision Oncology in Hospitals & Diagnostic Laboratories
Figure 13. Global Precision Oncology Market: Hospitals & Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 14. Precision Oncology in Healthcare Data Companies
Figure 15. Global Precision Oncology Market: Healthcare Data Companies (2021-2026) & ($ millions)
Figure 16. Global Precision Oncology Market Size Market Share by Application in 2025
Figure 17. Global Precision Oncology Revenue Market Share by Player in 2025
Figure 18. Global Precision Oncology Market Size Market Share by Region (2021-2026)
Figure 19. Americas Precision Oncology Market Size 2021-2026 ($ millions)
Figure 20. APAC Precision Oncology Market Size 2021-2026 ($ millions)
Figure 21. Europe Precision Oncology Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Precision Oncology Market Size 2021-2026 ($ millions)
Figure 23. Americas Precision Oncology Value Market Share by Country in 2025
Figure 24. United States Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Precision Oncology Market Size Market Share by Region in 2025
Figure 29. APAC Precision Oncology Market Size Market Share by Type (2021-2026)
Figure 30. APAC Precision Oncology Market Size Market Share by Application (2021-2026)
Figure 31. China Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 35. India Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Precision Oncology Market Size Market Share by Country in 2025
Figure 38. Europe Precision Oncology Market Size Market Share by Type (2021-2026)
Figure 39. Europe Precision Oncology Market Size Market Share by Application (2021-2026)
Figure 40. Germany Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 41. France Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Precision Oncology Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Precision Oncology Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Precision Oncology Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Precision Oncology Market Size 2027-2032 ($ millions)
Figure 54. APAC Precision Oncology Market Size 2027-2032 ($ millions)
Figure 55. Europe Precision Oncology Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Precision Oncology Market Size 2027-2032 ($ millions)
Figure 57. United States Precision Oncology Market Size 2027-2032 ($ millions)
Figure 58. Canada Precision Oncology Market Size 2027-2032 ($ millions)
Figure 59. Mexico Precision Oncology Market Size 2027-2032 ($ millions)
Figure 60. Brazil Precision Oncology Market Size 2027-2032 ($ millions)
Figure 61. China Precision Oncology Market Size 2027-2032 ($ millions)
Figure 62. Japan Precision Oncology Market Size 2027-2032 ($ millions)
Figure 63. Korea Precision Oncology Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Precision Oncology Market Size 2027-2032 ($ millions)
Figure 65. India Precision Oncology Market Size 2027-2032 ($ millions)
Figure 66. Australia Precision Oncology Market Size 2027-2032 ($ millions)
Figure 67. Germany Precision Oncology Market Size 2027-2032 ($ millions)
Figure 68. France Precision Oncology Market Size 2027-2032 ($ millions)
Figure 69. UK Precision Oncology Market Size 2027-2032 ($ millions)
Figure 70. Italy Precision Oncology Market Size 2027-2032 ($ millions)
Figure 71. Russia Precision Oncology Market Size 2027-2032 ($ millions)
Figure 72. Egypt Precision Oncology Market Size 2027-2032 ($ millions)
Figure 73. South Africa Precision Oncology Market Size 2027-2032 ($ millions)
Figure 74. Israel Precision Oncology Market Size 2027-2032 ($ millions)
Figure 75. Turkey Precision Oncology Market Size 2027-2032 ($ millions)
Figure 76. Global Precision Oncology Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Precision Oncology Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Precision Oncology Market Size 2027-2032 ($ millions)
Figure 1. Precision Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Precision Oncology Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Precision Oncology Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Precision Oncology Sales Market Share by Country/Region (2025)
Figure 8. Precision Oncology Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Precision Oncology Market Size Market Share by Type in 2025
Figure 10. Precision Oncology in Pharmaceutical & Biotechnology Companies
Figure 11. Global Precision Oncology Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 12. Precision Oncology in Hospitals & Diagnostic Laboratories
Figure 13. Global Precision Oncology Market: Hospitals & Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 14. Precision Oncology in Healthcare Data Companies
Figure 15. Global Precision Oncology Market: Healthcare Data Companies (2021-2026) & ($ millions)
Figure 16. Global Precision Oncology Market Size Market Share by Application in 2025
Figure 17. Global Precision Oncology Revenue Market Share by Player in 2025
Figure 18. Global Precision Oncology Market Size Market Share by Region (2021-2026)
Figure 19. Americas Precision Oncology Market Size 2021-2026 ($ millions)
Figure 20. APAC Precision Oncology Market Size 2021-2026 ($ millions)
Figure 21. Europe Precision Oncology Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Precision Oncology Market Size 2021-2026 ($ millions)
Figure 23. Americas Precision Oncology Value Market Share by Country in 2025
Figure 24. United States Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Precision Oncology Market Size Market Share by Region in 2025
Figure 29. APAC Precision Oncology Market Size Market Share by Type (2021-2026)
Figure 30. APAC Precision Oncology Market Size Market Share by Application (2021-2026)
Figure 31. China Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 35. India Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Precision Oncology Market Size Market Share by Country in 2025
Figure 38. Europe Precision Oncology Market Size Market Share by Type (2021-2026)
Figure 39. Europe Precision Oncology Market Size Market Share by Application (2021-2026)
Figure 40. Germany Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 41. France Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Precision Oncology Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Precision Oncology Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Precision Oncology Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Precision Oncology Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Precision Oncology Market Size 2027-2032 ($ millions)
Figure 54. APAC Precision Oncology Market Size 2027-2032 ($ millions)
Figure 55. Europe Precision Oncology Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Precision Oncology Market Size 2027-2032 ($ millions)
Figure 57. United States Precision Oncology Market Size 2027-2032 ($ millions)
Figure 58. Canada Precision Oncology Market Size 2027-2032 ($ millions)
Figure 59. Mexico Precision Oncology Market Size 2027-2032 ($ millions)
Figure 60. Brazil Precision Oncology Market Size 2027-2032 ($ millions)
Figure 61. China Precision Oncology Market Size 2027-2032 ($ millions)
Figure 62. Japan Precision Oncology Market Size 2027-2032 ($ millions)
Figure 63. Korea Precision Oncology Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Precision Oncology Market Size 2027-2032 ($ millions)
Figure 65. India Precision Oncology Market Size 2027-2032 ($ millions)
Figure 66. Australia Precision Oncology Market Size 2027-2032 ($ millions)
Figure 67. Germany Precision Oncology Market Size 2027-2032 ($ millions)
Figure 68. France Precision Oncology Market Size 2027-2032 ($ millions)
Figure 69. UK Precision Oncology Market Size 2027-2032 ($ millions)
Figure 70. Italy Precision Oncology Market Size 2027-2032 ($ millions)
Figure 71. Russia Precision Oncology Market Size 2027-2032 ($ millions)
Figure 72. Egypt Precision Oncology Market Size 2027-2032 ($ millions)
Figure 73. South Africa Precision Oncology Market Size 2027-2032 ($ millions)
Figure 74. Israel Precision Oncology Market Size 2027-2032 ($ millions)
Figure 75. Turkey Precision Oncology Market Size 2027-2032 ($ millions)
Figure 76. Global Precision Oncology Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Precision Oncology Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Precision Oncology Market Size 2027-2032 ($ millions)
